Case Report
Potentially Life-Threatening Phosphate Diabetes Induced by Ferric Carboxymaltose Injection: A Case Report and Review of the Literature
Table 2
Biological parameters of patients reported in the literature.
| | Blazevic et al. [13] | Mani et al. [14] |
Fierz et al. [15] | This case |
| Doses of Ferric carboxymaltose (gr) | 1 | 3 | 2 | 3 | 1.5 | 1 | 1 | P04 before administration (mg/dL) | ? | ? | ? | ? | ? | ? | 2.5 | Nadir P04 pl (mg/dL) | 0.78 | 1 | 0.68 | 0.8 | 0.5 | 0.56 | 0.93 | FEPO4 before administration (%) | ? | ? | ? | ? | ? | ? | 11 | FEPO4 after administration (%) | 59 | 12.4 | 23 | 28 | 9 | 77 | 23 | PTH | Elevation | normal range | Elevation, 16.7 pmol/L | ? | ? | Undetectable one week after first dose | Moderate elevation before administration. No change | Vitamin D
| Lower | Normal range | 28 nmol/L | ?
| 36 (48–60) | Normal range | 9 ng/mL | FGF23 (normal <125 Ru/mL) | 202 | | | 119 at six weeks | | | |
|
|